Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
FDA
Apr 23, 2024, 08:06 |
Blog
Vivek Subbiah: We’ve been to the moon, now to mars and beyond to Eradicate Cancer
Vivek Subbiah posted on X/Twitter: "We’ve been to the moon, now to mars and beyond…
Apr 22, 2024, 05:14 |
Insight
Chul Kim: In-depth review of BRAF mutant NSCLC by Dr. Marcelo Negrao at Texas Lung 24 Conference
Chul Kim, Thoracic Medical Oncologist at Georgetown University, shared a post on X: "In-depth review…
Apr 21, 2024, 18:27 |
Insight
Aradhana Kasimsetty: Denise Sabatino and I present a review of the known risks of AAV vector-mediated liver cancer
Aradhana Kasimsetty, Doctoral Candidate at the Perelman School of Medicine, shared on LinkedIn: “With the recent…
Apr 21, 2024, 18:22 |
Blog
Vivek Subbiah: Pleased to host a podcast interview with Roni Shouval on Secondary T-Cell Malignancies Following CAR T-Cell Therapy
Vivek Subbiah shared a post on X: “Secondary T-Cell Malignancies Following Chimeric antigen receptor (CAR) T-Cell…
Apr 21, 2024, 11:35 |
Insight
Samuel Kareff: Our pan-tumor analysis on the not-so-elusive HRAS mutation in solid tumors
Samuel Kareff, Hematology/Oncology Chief Fellow at the University of Miami Sylvester Comprehensive Cancer Center, shared…
Apr 21, 2024, 06:16 |
Dialogues
Oncodaily Dialogues #8 Mikkael Sekeres/ Hosted by Roupen Odabashian
In our ongoing series called “OncoDaily Dialogues”, we consistently feature prominent individuals in the field of…
Apr 20, 2024, 07:47 |
Drugs
Paper summary by Marco Donia
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared a post on…
Apr 19, 2024, 20:37 |
Societies
Vivek Subbiah: 4th ESMO webinar of the Precision Oncology series
Vivek Subbiah shared a post by Diogo Martins Branco, Board Member at AICSO, on X/Twitter,…
Apr 19, 2024, 06:09 |
Blog
Dr. Gilberto Lopes shares about his work in Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center shared on LinkedIn: "Gilberto Lopes, associate director of global oncology believes…
Apr 18, 2024, 13:58 |
Insight
Ben Derman: Should MRD negativity be accepted as a surrogate endpoint for clinical trials in myeloma
Ben Derman, Assistant Professor at the University of Chicago, shared on X/Twitter: "Should MRD negativity…
69
70
71
72
73
All:
951
Posts:
701 - 710
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube